4D Molecular Therapeutics, Inc. (FDMT) Financials

FDMT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 339.9 million 32.1 million
2023-09-30 361.6 million 31.7 million
2023-06-30 352.5 million 725.3 million
2023-03-31 244.0 million 25.4 million

FDMT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -25.2 million 5.9 million
2023-09-30 -1.6 million 4.6 million
2023-06-30 -22.9 million 5.0 million
2023-03-31 -28.9 million 4.2 million

FDMT Net Income

No data available :(

FDMT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 288.2 million - 14.7 million
2023-09-30 319.7 million - 15.2 million
2023-06-30 310.3 million - 15.6 million
2023-03-31 201.9 million - 15.7 million

FDMT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 39.1 million
2023-09-30 42.3 million
2023-06-30 38.3 million
2023-03-31 32.7 million

FDMT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 549000 26.0 million 10.6 million -
2023-09-30 405000 25.1 million 9.1 million -
2023-06-30 805000 23.6 million 8.8 million -
2023-03-31 1.0 million 22.4 million 8.0 million -

FDMT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 -19000 4.2 million
2023-09-30 20.2 million 1.4 million
2023-06-30 239000 1.4 million
2023-03-31 298000 1.4 million

FDMT

Price: $26.38

52 week price:
9.44
36.25

Earnings Per Share: -2.58 USD

P/E Ratio: -12.19

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 192795

Market Capitalization: 1.3 billion

Links: